Through the 90-day period concluding December 12, 2025, Roivant Sciences's top three insider stakeholders include TenPercentOwner Pharma Technologies Ltd. Dexcel (102.85Mn shares), TenPercentOwner Vivek Ramaswamy (47.01Mn shares), Other Financial Lp Qvt (18.05Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Pharma Technologies Ltd. Dexcel | 102,849,443 | 14 Nov, 2022 | |
| Investments (Uk) Ltd Svf | 73,031,667 | 02 Oct, 2023 | |
| Chemical Co., Ltd. Sumitomo | 71,251,083 | 26 Jun, 2023 | |
| Vivek Ramaswamy | 47,011,613 | 17 Nov, 2025 | |
| Daniel Allen Gold | 27,013,621 | 12 Sep, 2025 | |
| Keith S Manchester | 19,996,130 | 12 Sep, 2025 | |
| Mayukh Sukhatme | Pres&Chief Investment Officer | 18,836,547 | 26 Dec, 2024 |
| Financial Lp Qvt | 18,047,727 | 21 Nov, 2025 | |
| Matthew Gline | CEO | 17,287,081 | 18 Sep, 2025 |
| Frank Torti | President And Vant Chair | 13,736,547 | 01 Aug, 2025 |
| Global Performance Llc Viking | 12,884,307 | 26 Jun, 2023 | |
| Global Investors Lp Viking | 12,884,307 | 26 Jun, 2023 | |
| Eric Venker | President & Immunovant CEO | 1,497,908 | 11 Dec, 2025 |
| Richard Pulik | Cfo | 388,273 | 24 Nov, 2025 |
| Rakhi Kumar | Chief Accounting Officer | 162,306 | 24 Feb, 2025 |
| Ilan Oren | 118,388 | 22 Oct, 2025 | |
| Jennifer Humes | Chief Accounting Officer | 112,255 | 24 Mar, 2025 |
| James C Momtazee | 108,543 | 22 Oct, 2025 | |
| Melissa B, Epperly | 56,904 | 22 Oct, 2025 | |
| Andrew Lo | 52,142 | 19 Sep, 2022 | |
| Meghan Fitzgerald | 42,963 | 12 Sep, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Dec, 2025 | Eric Venker | Common Shares | A | 200,000 | $3.85 | 1,697,908 | D | M |
| 09 Dec, 2025 | Eric Venker | Common Shares | D | 200,000 | $20.85 | 1,497,908 | D | S |
| 20 Nov, 2025 | Richard Pulik | Common Shares | D | 1,235 | $20.27 | 388,273 | D | F |
| 20 Nov, 2025 | Eric Venker | Common Shares | D | 7,051 | $20.27 | 1,497,908 | D | F |
| 19 Nov, 2025 | Financial Lp Qvt | Common Shares | D | 850,000 | $20.25 | 18,497,727 | I | S |
| 19 Nov, 2025 | Keith S Manchester | Common Shares | D | 850,000 | $20.25 | 18,497,727 | I | S |
| 19 Nov, 2025 | Daniel Allen Gold | Common Shares | D | 850,000 | $20.25 | 18,497,727 | I | S |
| 19 Nov, 2025 | Financial Lp Qvt | Common Shares | D | 150,000 | $20.20 | 18,347,727 | I | S |
| 19 Nov, 2025 | Daniel Allen Gold | Common Shares | D | 150,000 | $20.20 | 18,347,727 | I | S |
| 19 Nov, 2025 | Keith S Manchester | Common Shares | D | 150,000 | $20.20 | 18,347,727 | I | S |
| 19 Nov, 2025 | Financial Lp Qvt | Common Shares | D | 125,000 | $20.16 | 18,222,727 | I | S |
| 19 Nov, 2025 | Daniel Allen Gold | Common Shares | D | 125,000 | $20.16 | 18,222,727 | I | S |
| 19 Nov, 2025 | Keith S Manchester | Common Shares | D | 125,000 | $20.16 | 18,222,727 | I | S |
| 19 Nov, 2025 | Keith S Manchester | Common Shares | D | 175,000 | $20.24 | 18,047,727 | I | S |
| 19 Nov, 2025 | Daniel Allen Gold | Common Shares | D | 175,000 | $20.24 | 18,047,727 | I | S |
| 19 Nov, 2025 | Financial Lp Qvt | Common Shares | D | 175,000 | $20.24 | 18,047,727 | I | S |
| 13 Nov, 2025 | Vivek Ramaswamy | Common Shares | D | 287,283 | $20.81 | 35,221,076 | D | S |
| 14 Nov, 2025 | Vivek Ramaswamy | Common Shares | D | 1,027,670 | $20.33 | 34,193,406 | D | S |
| 17 Nov, 2025 | Vivek Ramaswamy | Common Shares | D | 539,650 | $20.51 | 33,653,756 | D | S |
| 07 Nov, 2025 | Eric Venker | Common Shares | A | 200,000 | $3.85 | 1,704,959 | D | M |